Despite Fast-paced Momentum, Select Medical (SEM) Is Still a Bargain Stock
Select Medical (SEM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Here's Why Select Medical (SEM) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Take SEM Off the Menu? Executive Chairman Gives Premium Offer
Select Medical draws investor focus as its executive chairman offers a take-private idea at up to a 15.6% premium to the latest close.
Should Value Investors Buy Select Medical (SEM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical Down 5% Despite Q3 Earnings Beat on Patient Volumes
SEM's Q3 earnings drop 11.5% year over year due to the rising cost of services, despite a revenue beat and raised 2025 EPS guidance.
Why Select Medical (SEM) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Select Medical (SEM) Is Attractively Priced Despite Fast-paced Momentum
Select Medical (SEM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Are Investors Undervaluing Select Medical (SEM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical Holdings Corporation (SEM) Q3 2025 Earnings Call Transcript
Select Medical Holdings Corporation ( SEM ) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Robert Ortenzio - Co-Founder & Executive Chairman Thomas Mullin - Chief Executive Officer Michael Malatesta - Executive VP & CFO Conference Call Participants Benjamin Hendrix - RBC Capital Markets, Research Division Justin Bowers - Deutsche Bank AG, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Albert Rice - UBS Investment Bank, Research Division Presentation Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the third quarter 2025 results and the company's business outlook. Presenting today are the company's Executive Chairman and Co-Founder, Robert Ortenzio; the company's Chief Executive Officer, Thomas Mullin; and the company's Executive Vice President and Chief Financial Officer, Michael Malatesta.
Select Medical (SEM) Surpasses Q3 Earnings and Revenue Estimates
Select Medical (SEM) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.5 per share a year ago.
Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's What You Should Know
The mean of analysts' price targets for Select Medical (SEM) points to a 36.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
